Article | November 18, 2020

Introduction To Decentralized Clinical Trials

Source: Rho
COVID 19 Business

Many terms are used to describe decentralized clinical trials (DCTs) such as ‘virtual’, ‘remote’, ‘site-less’, and ‘hybrid’ but what is the exact definition? The FDA recently defined DCTs as the decentralization of clinical trial operations where technology is used to communicate with study participants and collect data. They also clarified that DCTs should not be confused with virtual trials which are based on computer models and do not use real participants but computer programs to model participants to assess drug efficacy and safety during the preclinical phase.

This blog clarifies the definition of DCTs and highlights their benefits and associated technologies.

VIEW THE ARTICLE!
Signing up provides unlimited access to:
Signing up provides unlimited access to:
  • Trend and Leadership Articles
  • Case Studies
  • Extensive Product Database
  • Premium Content
HELLO. PLEASE LOG IN. X

Not yet a member of Clinical Leader? Register today.

ACCOUNT SIGN UP X
Please fill in your account details
Login Information
ACCOUNT SIGN UP

Subscriptions

Sign up for the newsletter that brings you the industry's latest news, technologies, trends and products.

You might also want to: